Skip to main content

Table 1 Pazopanib in advanced desmoplastic small round cell tumour

From: Pazopanib in advanced desmoplastic small round cell tumours: a multi-institutional experience

Case Age at onset of pazopanib Sex PS Site of metastases Starting dose (mg) Dose reduction Best response PFS (months) OS (months)
1 21 M 2 Peritoneum, liver, kidney 600 N PD 0.5 2.1
2 22 M 1 Peritoneum 800 Y SD 9.2 9.7
3 47 M 1 Peritoneum, liver 800 N PR 16.3 25.8
4 21 M 1 Peritoneum, liver 800 N SD 3.9 9.2
5 30 M 0 Peritoneum, lung, lymph nodes, liver 800 Y PD 2.5 7.4
6 33 M 0 Peritoneum, liver 800 Y SD 9.4 15.4
7 20 M 1 Peritoneum, lung, bone 800 N SD 4.4 26
8 30 M 0 Peritoneum, liver, lymphnodes 800 N SD 9.9 26.7*
9 30 M 0 Peritoneum, liver 800 N PR 13.1 13.8*
  1. *Still alive.